Tren Enanthate
Tren Enanthate
Long-acting Trenbolone ester. Same powerful effects with less frequent injections. Ideal for extended cutting and recomposition cycles.
Save 10% when you pay in crypto (BTC · ETH · USDT)
Free shipping on orders over $250
Research use only. Products are not intended for human consumption.
We accept
Interac e-Transfer · BTC · ETH · USDT crypto −10%
How ordering works
- 01Place your order — no payment is taken on this site.
- 02Payment instructions arrive by email reply (Interac e-Transfer or crypto).
- 03Paid before 4 PM EST → same-day dispatch with tracking number.
Refrigerated SKU? Ships in an insulated cold-pack mailer. You receive a packaging photograph within 4 hours of dispatch.
- Janoshik verified — per-batch third-party purity testing
- Discreet — plain packaging, no brand markings
- Cold-pack mailer for refrigerated SKUs
- Refund + retest if a batch fails purity
Complete protocols
Build your stack
Stacks that include Tren Enanthate — protocol components priced together, bulk savings applied automatically.
At a glance
At a glance
- Concentration
- 200mg/ml
- Purity
- USP-equivalent ≥98%
- Route
- Intramuscular injection
- Storage
- Room temperature, protect from light.
Compound profile
Trenbolone Enanthate delivers the full pharmacological payload of Trenbolone — the 500:500 anabolic-to-androgenic profile, the glucocorticoid receptor antagonism, the nutrient partitioning, the zero aromatization — attached to a seven-carbon enanthate ester that extends the compound's active duration. Chemically, the active hormone is identical to Trenbolone Acetate; only the release kinetics differ. The enanthate ester produces a more gradual absorption curve, a longer time to peak serum concentration, and a terminal half-life of approximately 5-7 days.
Trenbolone Enanthate delivers the full pharmacological payload of Trenbolone — the 500:500 anabolic-to-androgenic profile, the glucocorticoid receptor antagonism, the nutrient partitioning, the zero aromatization — attached to a seven-carbon enanthate ester that extends the compound's active duration. Chemically, the active hormone is identical to Trenbolone Acetate; only the release kinetics differ. The enanthate ester produces a more gradual absorption curve, a longer time to peak serum concentration, and a terminal half-life of approximately 5-7 days.
The mechanism of action is the same as Trenbolone Acetate in every respect. The enanthate ester simply governs how the drug enters systemic circulation — not what it does once it arrives. Androgen receptor binding, protein synthesis upregulation, cortisol antagonism, nutrient partitioning enhancement, and erythropoietin stimulation all proceed identically. The practical difference is in serum level stability: the longer ester produces smoother concentration curves with less peak-to-trough variation, which some researchers find correlates with fewer acute side effects (particularly night sweats and insomnia).
Tren Enanthate is favored by researchers who have already established their Trenbolone tolerance with the acetate ester and are ready to reduce their injection frequency. The twice-weekly (or even once-weekly) administration schedule is substantially more convenient than the daily or every-other-day protocol required by Tren Ace. The trade-off is slower onset (meaningful results typically appear at weeks 3-4 versus week 1-2 with acetate) and slower clearance if adverse effects necessitate discontinuation.
This compound is for advanced researchers only — the same qualification applies as with Tren Acetate, with the additional caveat that Tren Enanthate is not the ideal first Trenbolone experience. The long ester means that if a researcher discovers poor Trenbolone tolerance, they face 2-3 weeks of declining (but still active) hormone levels after stopping, versus 3-4 days with acetate. Researchers new to Trenbolone should always trial with the acetate ester first to establish tolerance before committing to the longer-acting preparation.
Tren Enanthate is typically administered twice weekly (every 3.5 days) for optimal serum stability. It pairs with Testosterone Enanthate or Cypionate for ester-matched convenience, avoiding the complexity of mixing short and long esters on different injection schedules. The same ancillary requirements apply: testosterone base, cabergoline availability for prolactin management, LC-MS/MS estradiol testing, and cardiovascular monitoring. Post-cycle therapy should begin approximately 14 days after the final injection, once circulating ester levels have sufficiently declined. Cycle length typically runs 10-12 weeks.
How to use
Injection technique, site rotation, and frequency guidance. Typical protocols split the weekly dose into 2 injections.
Dose ranges published in the peptide-research literature vary considerably. Research protocols should be designed by a qualified researcher and use the lowest effective dose consistent with the hypothesis being tested. Half-life determines dosing frequency — shorter half-lives usually require daily dosing, while long-acting analogues tolerate weekly administration.
For compound-specific dose theory, see the half-life dosing math guide and the stacking theory reference.
Independent lab verification
Research disclaimer
For research and laboratory use only. Not for human or veterinary consumption. Nova Pharma sells to qualified researchers of legal age and ships to Canadian addresses only. See disclaimer and terms.
At a glance
At a glance
- Concentration
- 200mg/ml
- Purity
- USP-equivalent ≥98%
- Route
- Intramuscular injection
- Storage
- Room temperature, protect from light.
Compound profile
Trenbolone Enanthate delivers the full pharmacological payload of Trenbolone — the 500:500 anabolic-to-androgenic profile, the glucocorticoid receptor antagonism, the nutrient partitioning, the zero aromatization — attached to a seven-carbon enanthate ester that extends the compound's active duration. Chemically, the active hormone is identical to Trenbolone Acetate; only the release kinetics differ. The enanthate ester produces a more gradual absorption curve, a longer time to peak serum concentration, and a terminal half-life of approximately 5-7 days.
Trenbolone Enanthate delivers the full pharmacological payload of Trenbolone — the 500:500 anabolic-to-androgenic profile, the glucocorticoid receptor antagonism, the nutrient partitioning, the zero aromatization — attached to a seven-carbon enanthate ester that extends the compound's active duration. Chemically, the active hormone is identical to Trenbolone Acetate; only the release kinetics differ. The enanthate ester produces a more gradual absorption curve, a longer time to peak serum concentration, and a terminal half-life of approximately 5-7 days.
The mechanism of action is the same as Trenbolone Acetate in every respect. The enanthate ester simply governs how the drug enters systemic circulation — not what it does once it arrives. Androgen receptor binding, protein synthesis upregulation, cortisol antagonism, nutrient partitioning enhancement, and erythropoietin stimulation all proceed identically. The practical difference is in serum level stability: the longer ester produces smoother concentration curves with less peak-to-trough variation, which some researchers find correlates with fewer acute side effects (particularly night sweats and insomnia).
Tren Enanthate is favored by researchers who have already established their Trenbolone tolerance with the acetate ester and are ready to reduce their injection frequency. The twice-weekly (or even once-weekly) administration schedule is substantially more convenient than the daily or every-other-day protocol required by Tren Ace. The trade-off is slower onset (meaningful results typically appear at weeks 3-4 versus week 1-2 with acetate) and slower clearance if adverse effects necessitate discontinuation.
This compound is for advanced researchers only — the same qualification applies as with Tren Acetate, with the additional caveat that Tren Enanthate is not the ideal first Trenbolone experience. The long ester means that if a researcher discovers poor Trenbolone tolerance, they face 2-3 weeks of declining (but still active) hormone levels after stopping, versus 3-4 days with acetate. Researchers new to Trenbolone should always trial with the acetate ester first to establish tolerance before committing to the longer-acting preparation.
Tren Enanthate is typically administered twice weekly (every 3.5 days) for optimal serum stability. It pairs with Testosterone Enanthate or Cypionate for ester-matched convenience, avoiding the complexity of mixing short and long esters on different injection schedules. The same ancillary requirements apply: testosterone base, cabergoline availability for prolactin management, LC-MS/MS estradiol testing, and cardiovascular monitoring. Post-cycle therapy should begin approximately 14 days after the final injection, once circulating ester levels have sufficiently declined. Cycle length typically runs 10-12 weeks.
How to use
Injection technique, site rotation, and frequency guidance. Typical protocols split the weekly dose into 2 injections.
Dose ranges published in the peptide-research literature vary considerably. Research protocols should be designed by a qualified researcher and use the lowest effective dose consistent with the hypothesis being tested. Half-life determines dosing frequency — shorter half-lives usually require daily dosing, while long-acting analogues tolerate weekly administration.
For compound-specific dose theory, see the half-life dosing math guide and the stacking theory reference.
Independent lab verification
Research disclaimer
For research and laboratory use only. Not for human or veterinary consumption. Nova Pharma sells to qualified researchers of legal age and ships to Canadian addresses only. See disclaimer and terms.
Read the research
Reference articles from the lab covering this compound.
comparisons
Tren Ace vs Tren Enanthate: Choosing Your Trenbolone Ester
Compare Trenbolone Acetate vs Trenbolone Enanthate — half-lives, injection frequency, side effect management, first cycle recommendations, and dosing equivalencies. Complete ester comparison guide.
compound guides
Tren Hex (Parabolan): The Legendary French Trenbolone Made for Humans
Parabolan (trenbolone hexahydrobenzylcarbonate) was the only trenbolone ever approved for human use. Learn about Tren Hex's 14-day half-life, dosing protocols, comparisons to Tren Ace and Tren E, and why this legendary French compound still commands prestige among advanced users.
safety and sourcing
Managing Tren Side Effects: Night Sweats, Insomnia, Cough & Mental Changes
Complete guide to managing trenbolone side effects — night sweats, insomnia, tren cough, mental changes, cardiovascular impact, and prolactin. Evidence-based mitigation strategies for every side effect.
